Loading…
Cryo-Cell International, Inc. is projected to rise to $4.55 by 2027, a +34% move from its current price of $3.39. CCEL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.30 | $3.39 | $3.49 | +0.06% |
| May 30 | $3.26 | $3.39 | $3.53 | +0.12% |
| May 31 | $3.23 | $3.40 | $3.57 | +0.18% |
| Jun 1 | $3.21 | $3.40 | $3.60 | +0.24% |
| Jun 2 | $3.19 | $3.40 | $3.62 | +0.30% |
| Jun 3 | $3.17 | $3.40 | $3.65 | +0.36% |
| Jun 4 | $3.16 | $3.40 | $3.67 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.16 | $3.40 | $3.67 | +0.42% |
| Week 2 | $3.07 | $3.42 | $3.80 | +0.84% |
| Week 3 | $3.01 | $3.43 | $3.91 | +1.27% |
| Week 4 | $2.96 | $3.45 | $4.01 | +1.69% |
| Week 5 | $2.92 | $3.46 | $4.10 | +2.12% |
| Week 6 | $2.89 | $3.48 | $4.18 | +2.55% |
| Week 7 | $2.86 | $3.49 | $4.26 | +2.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use.
It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Cryo-Cell International, Inc. (CCEL) operates in the Healthcare sector. The current price is $3.46 and the market cap is $27.87M, with a rank of 4839. This places the stock among smaller-cap healthcare names with a focused niche in cryopreservation services.
Near term, the stock’s technicals are mixed but tend toward a neutral stance. The 50-day simple moving average is $3.46 and the 200-day simple moving average is $3.88, with near-term support at $3.41 and resistance at $4.08. The 30-day price range spans $2.84 to $4.22, illustrating a relatively tight trading window.
Overall, the forecast landscape shows a flat first year in 2026 (avg $3.46, min $2.89, max $4.70; ROI 0; sentiment NEUTRAL) followed by a bullish multi-year trajectory. From 2027 onward, averages rise steadily toward mid-teens by 2050, with increasing upside potential and higher max scenarios noted in the later years.
A major floor 14.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 20.4% above — a clean break opens room to run.
A major ceiling 27.1% above — clearing it would confirm fresh momentum.
Key CCEL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CCEL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.44 | Sell | $3.43 | Sell |
| MA 10 | $3.50 | Sell | $3.47 | Sell |
| MA 20 | $3.50 | Sell | $3.50 | Sell |
| MA 50 | $3.48 | Sell | $3.49 | Sell |
| MA 100 | $3.42 | Sell | $3.57 | Sell |
| MA 200 | $3.86 | Sell | $3.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.78 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -135.17 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -1.74 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.01 | Sell |
| Awesome (5,34) | -0.12 | Sell |
| Ultimate (7,14,28) | 23.05 | Buy |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 3.38 | Buy |
| ADX (14) | 7.66 | Neutral |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 50, and the stock trades with the 50-day moving average at $3.46 while the 200-day moving average sits at $3.88. Near-term support is identified at $3.41 and resistance at $4.08, framing a modestly range-bound setup.
The 30-day range runs from a low of $2.84 to a high of $4.22, underscoring a relatively narrow near-term trading band. Traders may watch for a breakout above $4.08 or a breakdown below $3.41 to confirm a shift in momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.89 | $3.39 | $4.54 | 0% | Neutral | |
| $3.59 | $4.55 | $6.12 | +34% | Bullish | |
| $3.60 | $4.70 | $6.55 | +39% | Bullish | |
| $3.42 | $4.56 | $6.55 | +35% | Bullish | |
| $3.72 | $5.07 | $7.47 | +50% | Bullish | |
| $3.67 | $5.10 | $7.67 | +50% | Bullish | |
| $4.01 | $5.68 | $8.70 | +67% | Bullish | |
| $4.84 | $6.97 | $10.87 | +106% | Bullish | |
| $5.09 | $7.45 | $11.82 | +120% | Bullish | |
| $5.48 | $8.14 | $13.11 | +140% | Bullish | |
| $7.20 | $11.47 | $19.68 | +238% | Bullish | |
| $10.46 | $18.85 | $35.45 | +456% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.89 | $3.39 | $4.00 | +0.00% |
| June 2026 | $3.02 | $3.55 | $4.28 | +4.84% |
| July 2026 | $3.02 | $3.58 | $4.37 | +0.75% |
| August 2026 | $2.91 | $3.47 | $4.28 | -3.08% |
| September 2026 | $2.91 | $3.50 | $4.35 | +0.76% |
| October 2026 | $2.98 | $3.60 | $4.52 | +2.94% |
| November 2026 | $2.94 | $3.57 | $4.51 | -0.92% |
| December 2026 | $2.93 | $3.57 | $4.54 | -0.01% |
Click any year to see its month-by-month CCEL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CCEL could reach as high as $4.54, with a base case around $3.39 and support toward $2.89 — roughly 0% from $3.39. Price action looks broadly range-bound.
Expect CCEL to range from $3.59 to $6.12 through 2027. The $4.55 average target implies a +34% move from current prices. That is up +34% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The CCEL price prediction for 2028 points to an average of $4.70 (low $3.60, high $6.55) — a potential gain of +39% on today's $3.39. Momentum favours further upside here.
In 2029, CCEL is projected to trade between $3.42 and $6.55, averaging $4.56 — a potential gain of +35% from today's $3.39. That is -3% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Cryo-Cell International, Inc.'s 2030 outlook centres on $5.07, within a $3.72 to $7.47 range. That is up +11% on the projected 2029 average. That marks a +50% change versus current levels. Momentum favours further upside here.
By 2031, CCEL could reach as high as $7.67, with a base case around $5.10 and support toward $3.67 — roughly +50% from $3.39. Buyers look set to stay in control over this stretch.
Expect CCEL to range from $4.01 to $8.70 through 2032. The $5.68 average target implies a +67% move from current prices. That is up +11% on the projected 2031 average. Momentum favours further upside here.
The CCEL price prediction for 2033 points to an average of $6.97 (low $4.84, high $10.87) — a potential gain of +106% on today's $3.39. Buyers look set to stay in control over this stretch.
In 2034, CCEL is projected to trade between $5.09 and $11.82, averaging $7.45 — a potential gain of +120% from today's $3.39. That is up +7% on the projected 2033 average. Momentum favours further upside here.
Cryo-Cell International, Inc.'s 2035 outlook centres on $8.14, within a $5.48 to $13.11 range. That is up +9% on the projected 2034 average. That marks a +140% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CCEL could reach as high as $19.68, with a base case around $11.47 and support toward $7.20 — roughly +238% from $3.39. Momentum favours further upside here.
Expect CCEL to range from $10.46 to $35.45 through 2050. The $18.85 average target implies a +456% move from current prices. That is up +64% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CCEL today (≈ 294.985251 CCEL) could be worth
$5,560.45
+$4,560.45 (+456%) by 2050 · US Dollar
Based on the average projected CCEL price of $18.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CCELwould be worth at today's price.
$1,000 invested in CCEL on May 27, 2025 (≈ 205.338814 CCEL) would be worth
$696.1
-$303.9 (-30.4%) today · 0.70× · US Dollar
Based on a CCEL entry price of $4.87 vs. today's $3.39.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.49 | $971.35 | -2.9% |
| 1 month ago | $4.08 | $830.88 | -16.9% |
| 3 months ago | $3.41 | $994.13 | -0.6% |
| 6 months ago | $4.3 | $788.37 | -21.2% |
| 1 year ago | $4.87 | $696.1 | -30.4% |
| All time (5.0y) ago | $8.65 | $391.91 | -60.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CCEL forecast.
Our base-case forecast reaches $6.80 around 2033.
Implied market cap at $6.80: $54.78M
The multi-year forecast shows a bullish trend beginning after 2026. In 2026 the avg price is $3.46 with an ROI of 0 and NEUTRAL sentiment. By 2027 the avg rises to $4.72 with an ROI of 36.5 and a BULLISH sentiment, expanding further through 2028 ($4.82, ROI 39.3; BULLISH) and 2029 ($4.69, ROI 35.6; BULLISH).
In 2030 the avg is projected at $5.27 with a max of $7.85 and a min of $3.82, delivering an ROI of 52.3 and a BULLISH sentiment. The trajectory continues higher into 2031 (avg $5.24, ROI 51.6) and 2032 (avg $5.91, ROI 70.7), with 2033 reaching an avg of $7.34 and a max of $11.63 (ROI 112.2; BULLISH).
The longer-range view shows substantial upside, with 2034 avg $7.78, 2035 avg $8.57, and 2040 avg $12.07 (ROI 248.8; BULLISH). By 2050 the forecast envisions an avg of $19.95, a min of $10.71, and a max of $38.36 (ROI 476.7; BULLISH).
Overall, the forecast portrays a rising long-term path with bullish sentiment for most years after 2026, though these are estimates and not guarantees. Investors should regard these figures as directional and subject to change with factors affecting the healthcare and biostorage sectors.
Tap a question to reveal the answer.
2030 forecast: min $3.82, avg $5.27, max $7.85; ROI 52.3; sentiment BULLISH.
The 2026 outlook is neutral with avg $3.46 and ROI 0, but the forecast shows a bullish trend from 2027 onward, with averages rising to $5.24 by 2031, $12.07 by 2040, and $19.95 by 2050, with increasing upside and higher max values in later years.
Yes. The 2033 forecast lists a max of $11.63 (min $5.03, avg $7.34) and a bullish outlook thereafter.
The near-term picture is NEUTRAL. The 30-day range is $2.84 to $4.22, RSI14 is 50, SMA50 is $3.46, SMA200 is $3.88, with support at $3.41 and resistance at $4.08.
Current price is $3.46 and market cap is $27.87M, with a rank of 4839.
Cryo-Cell International, Inc. Community Discussion
0Share your Cryo-Cell International, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.